Determination of ultra-low concentrations of gaseous 14 C-bearing hydrocarbons produced during corrosion of irradiated steel using accelerator mass spectrometry
- 9 October 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 145 (24) , 7870-7883
Abstract
Compound specific radiocarbon analysis, based on gas chromatography and accelerator mass spectrometry, was developed to quantify gaseous 14 C species released at pico- to femtomolar concentrations during alkaline anoxic corrosion of irradiated steel.Keywords
Funding Information
- Seventh Framework Programme (604779)
This publication has 18 references indexed in Scilit:
- Processes leading to reduced and oxidised carbon compounds during corrosion of zero-valent iron in alkaline anoxic conditionsChemosphere, 2020
- Quantification of dissolved organic14C-containing compounds by accelerator mass spectrometry in a corrosion experiment with irradiated steelRadiocarbon, 2018
- Analysis of 14 C-bearing compounds released by the corrosion of irradiated steel using accelerator mass spectrometryThe Analyst, 2018
- Formation of Low-Molecular-Weight Organic Compounds During Anoxic Corrosion of Zero-Valent IronEnvironmental Engineering Science, 2018
- Formation and stability of14C-containing organic compounds in alkaline iron-water systems: preliminary assessment based on a literature survey and thermodynamic modellingMineralogical Magazine, 2015
- Determination of the 14C Content in Activated Steel Components from a Neutron Spallation Source and a Nuclear Power PlantAnalytical Chemistry, 2014
- Corrosion Behavior of Carbon Steel Radioactive Waste Packages: A Summary Review of Swedish and U.K. ResearchCorrosion, 2009
- Life cycle and management of carbon-14 from nuclear power generationProgress in Nuclear Energy, 2006
- Anaerobic Corrosion of Carbon Steel and Cast Iron in Artificial Groundwaters: Part 1—Electrochemical AspectsCorrosion, 2002
- Bioanalytical Applications of Accelerator Mass Spectrometry for Pharmaceutical ResearchCurrent Pharmaceutical Design, 2000